Mariposa Health Overview
- Founded
- 2008
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 2
Mariposa Health General Information
Description
Provider of health and pharmaceutical research and development services intended to focus on the development and commercialisation of treatments for conditions causing chronically poor airflow to the lungs. The company's health and pharmaceutical research and development services include a novel anti-inflammatory/anti-oxidant and an oral bacterial vaccine, form our two-pronged complementary approach to the treatment of Chronic Obstructive Pulmonary Disease (COPD) from its early to severe stages enabling patients to get products for undertreated conditions, primarily those of the airways from the mouth and nose to the lungs.
Contact Information
Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Mariposa Health US
Primary Office
- 61 Avalon Parade
- Unit 6
- Avalon Beach, New South Wales 2107
- Australia
Mariposa Health Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Mariposa Health‘s full profile, request access.
Request a free trialMariposa Health Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Phillip Comans | Managing Director, Executive Chairman, Founder & President |
Mariposa Health Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000000 | Mariposa Health | Managing Director, Executive Chairman, Founder & President | 000 0000 |